# A Phase 1 Study of PVT401 in Healthy Subjects

> **NCT07423000** · PHASE1 · RECRUITING · sponsor: **Parvus Therapeutics, Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)

## Interventions

- **DRUG:** PVT401
- **DRUG:** Normal Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07423000
- **Lead sponsor:** Parvus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423000, "A Phase 1 Study of PVT401 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07423000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*